Hepatitis C virus and insulin resistance/diabetes mellitus

Gastroenterology and Hepatology

Volumn 4, Issue 8, 2008, Pages 568-570

  Torres, Dawn M ^a   Harrison, Stephen A ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LONG ACTING INSULIN; PEGINTERFERON; RIBAVIRIN;

DIABETIC KETOACIDOSIS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; GENOTYPE; GLUCOSE HOMEOSTASIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPOGLYCEMIA; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER FIBROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PLASMAPHERESIS; REVIEW; TREATMENT RESPONSE;

EID: 51849163806     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Hui JM, Sud A, Farrell GC, Bandara P, Byth K, et al. Insulin resistance is associated with chronic hepatitis C virus infecrion and fibrosis progression. Gastroenterology. 2003;125:1695-1704.
2. Hickman IJ, Powell EE, Prins JB, Clouston AD, Ash S, et al. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J Hepatol. 2003;39:1043-1048.
3. Romero-Gomez M, Del Mar Viloria M, Andrade RJ, Salmeron J, Diago M, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis patients. Gastroenterology. 2005;128:636-641.
4. Poustchi H, Negro F, Hui J, Cua IH, Brandt LR, et al. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3. J Hepatol. 2008;48:28-34.
5. Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum hepatitis C virus RNA level, and liver fibrosis. Gastroenterology. 2008;134:416-423.
6. Kita Y, Mizukoshi E, Takamura T, Sakurai M, Takata Y, et al. Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus. Metabolism. 2007;56:1682-1688.
7. Khokhar O, Fischer J. Severe insulin resistance in a treatment-naive chronic hepatitis C patient. Gastroenterol Hepatol. 2008;4:567-568.
8. Oliveira BR, Magalhies O, Furlanetto TW, Bertoluci MC. Increased insulin resistance and hyperinsulinemia in patients with type 2 diabetes and chronic hepatitis C. Diabetes Res Clin Tract. 2008;79:e11-e12.
9. Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Tsukamoto K, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology. 2004;126;840-848.
10. Vidali M, Tripodi MF, Ivaldi A, Zampino R, Occhino G, et al. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. J Hepatol. 2008;48:399-406.
11. Hickman IJ, Macdonald GA. Impact of diabetes on the severity of liver disease. Am J Med. 2007;120:829-834.
12. Holstein A, Hinze S, Thiessen E, Plaschke A, Egberts EH. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol. 2002;17:677-681.
13. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcoholic or cholestatic disease. J Hepatol. 2000;32:209-217.